INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED, HUANG, HARRY, LINEBERRY, NEIL, RAIZER, JEFFREY FILES APPLICATION FOR "DAZOSTINAG OR CONJUGATES THEREOF FOR TREATMENT OF ADENOID CYSTIC CARCINOMAS"

GENEVA, March 17 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chome, Chuo-kuOsaka-shi, Osaka 541-0045), HUANG, Harry (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), LINEBERRY, Neil (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), RAIZER, Jeffrey (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142) filed a patent application (PCT/IB2025/058947) for "DAZOSTINAG OR CONJUGATES THEREOF FOR TREATMENT OF ADENOID CYSTIC CARCINOMAS" on Sep 05, 2025. With publication no. WO/2026/053159, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was su...